Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells
- 1 January 1993
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 29 (16), 2256-2264
- https://doi.org/10.1016/0959-8049(93)90218-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Antiestrogen Resistance: Mechanisms by Which Breast Cancer Cells Undermine the Effectiveness of Endocrine TherapyJNCI Journal of the National Cancer Institute, 1991
- A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancerBritish Journal of Cancer, 1989
- Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cellsBritish Journal of Cancer, 1989
- Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and stability of the resistant phenotypeBritish Journal of Cancer, 1989
- Biology and mode of action of pure antioestrogensJournal of Steroid Biochemistry, 1988
- Human breast cancer in the athymic nude mouse: Cystostatic effects of long-term antiestrogen therapyEuropean Journal of Cancer and Clinical Oncology, 1987
- Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell linesBritish Journal of Cancer, 1986
- Selection and Characterization of a Breast Cancer Cell Line Resistant to the Antiestrogen LY 117018Endocrinology, 1985
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2JNCI Journal of the National Cancer Institute, 1973